The authors regret that in the originally published version of this article, there was an error in Figure 4. In the “Placebo + NSAI” arm, the number of events was incorrectly reported as 162. The correct number is 132. The corrected figure is given below.
Corrigendum to “Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3”
Annals of Oncology | | M.P. Goetz, M. Toi, J. Huober, J. Sohn, O. Trédan, I.H. Park, M. Campone, S.-C. Chen, L.M. Manso, S. Paluch-Shimon, O.C. Freedman, J. O’Shaughnessy, X. Pivot, S.M. Tolaney, S.A. Hurvitz, A. Llombart-Cussac, V. André, A. Saha, G. van Hal, A. Shahir, H. Iwata, S.R.D. Johnston
Topics: breast-cancer, blood-cancer, clinical-trials